Taken together, IL-32 could be a putative biomarker for assessing inflammatory burden (i.e., disease activity) and the isoform IL-32γ could be a biomarker for bone resorption in RA (Table 1). The gene discussed is IL32; the disease is rheumatoid arthritis.